Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Navigating Regulations: A Guide for Life Sciences Companies in California

Feb 19, 2026

Understanding the Regulatory Landscape

California's life sciences sector is a thriving hub of innovation, but navigating the state's complex regulatory environment can be daunting. From biotechnology to pharmaceuticals, life sciences companies must comply with a myriad of state and federal regulations that govern everything from clinical trials to product distribution. Understanding these regulations is crucial for maintaining compliance and fostering growth.

Key agencies such as the California Department of Public Health (CDPH) and the U.S. Food and Drug Administration (FDA) play significant roles in regulating the industry. Companies must ensure that they are familiar with the guidelines set forth by these bodies to avoid potential legal issues.

california life sciences

Key Regulations to Consider

Clinical Trials and Research

Conducting clinical trials in California requires adherence to strict protocols and ethical standards. The Institutional Review Board (IRB) plays a pivotal role in reviewing and approving research proposals to ensure participant safety and ethical integrity. Companies must submit detailed plans and obtain necessary approvals before commencing trials.

Additionally, compliance with the Health Insurance Portability and Accountability Act (HIPAA) is crucial when handling sensitive patient information during research. Safeguarding data privacy is not just a legal obligation but also a cornerstone of ethical research practices.

clinical trials

Manufacturing and Distribution

Life sciences companies must also navigate regulations related to the manufacturing and distribution of products. The FDA's Current Good Manufacturing Practice (CGMP) regulations are designed to ensure the safety and efficacy of products. Companies must establish rigorous quality control systems and conduct regular audits to comply with these standards.

In California, additional state-specific regulations may apply, including environmental regulations that impact waste disposal and emissions. Staying informed about these requirements is essential for maintaining operational compliance.

manufacturing compliance

Strategies for Successful Compliance

Building a Compliance Team

One effective strategy for navigating the regulatory landscape is to build a dedicated compliance team. This team should consist of experts who understand both federal and state regulations. Their primary role is to ensure that the company adheres to all legal requirements and stays updated with any changes in legislation.

Training and continuous education are vital for compliance teams to remain effective. Regular workshops and seminars can help keep the team informed about the latest regulatory developments.

Utilizing Technology

Leveraging technology can also streamline compliance efforts. Digital tools and software solutions can assist in tracking regulatory requirements and managing documentation. Automation can reduce the risk of human error and ensure timely submissions of necessary filings and reports.

Implementing a robust compliance management system can provide a comprehensive overview of the company's regulatory status, helping to identify potential areas of risk before they become significant issues.

compliance technology

Conclusion

Navigating the regulatory landscape in California's life sciences industry requires diligence, expertise, and strategic planning. By understanding the key regulations, building a knowledgeable compliance team, and utilizing technology, companies can effectively manage compliance challenges. Staying proactive and informed will not only help in avoiding legal pitfalls but also contribute to the sustainable growth and success of the business.